Potentiation of Low-Dose Doxorubicin Cytotoxicity by Affecting P-Glycoprotein through Caryophyllane Sesquiterpenes in HepG2 Cells: An In Vitro and In Silico Study

Doxorubicin represents a valuable choice for different cancers, although the severe side effects occurring at the high effective dose limits its clinical use. In the present study, potential strategies to potentiate low-dose doxorubicin efficacy, including a metronomic schedule, characterized by a s...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Sotto, Antonella, Irannejad, Hamid, Eufemi, Margherita, Mancinelli, Romina, Abete, Lorena, Mammola, Caterina Loredana, Altieri, Fabio, Mazzanti, Gabriela, Di Giacomo, Silvia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7014471/
https://www.ncbi.nlm.nih.gov/pubmed/31963614
http://dx.doi.org/10.3390/ijms21020633

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7014471/
https://www.ncbi.nlm.nih.gov/pubmed/31963614
http://dx.doi.org/10.3390/ijms21020633

Ejemplares similares